KRISTEN KOONTZ: Open Payments
NPI 1790412864 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 15 payments from 4 companies in 2025. Trend: 2023 $2,749 · 2024 $921 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $267 |
| ABBVIE INC. | 1 | $30 |
| MERZ NORTH AMERICA, INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: NEMLUVIO, DYSPORT, BOTOX, Xeomin, Rhapsido.
Industry payments across TX — which companies pay providers there.
